# Case Report: A case of ovarian carcinoma manifesting with chest tightness as the initial clinical presentation accompanied by marked elevation of pleural effusion amylase levels

**Authors:** Guo-Yu Ou, Yin-Chuan Zhu, Kun Li, Cheng-Jie Li, Xin Yi, Qiu-Bin Wan, Hai-Lan Shen

PMC · DOI: 10.3389/fonc.2026.1616309 · Frontiers in Oncology · 2026-01-20

## TL;DR

A case of ovarian cancer presented with chest tightness and high amylase levels in pleural fluid, highlighting the importance of considering rare symptoms and lab results in diagnosis.

## Contribution

Highlights an atypical presentation of ovarian cancer with elevated pleural effusion amylase levels as a diagnostic clue.

## Key findings

- Ovarian cancer presented with chest tightness and markedly elevated pleural fluid amylase levels.
- Amylase levels normalized after treatment, suggesting a potential role in monitoring disease response.
- Atypical symptoms and lab indicators can aid in early differentiation of ovarian cancer.

## Abstract

This article reports a case of ovarian cancer presenting with chest tightness as the initial symptom, accompanied by markedly elevated pleural fluid amylase. A middle-aged female patient sought medical attention for “chest tightness and wheezing” as her primary complaints. Imaging revealed a massive pleural effusion with significantly elevated serum and pleural fluid amylase levels. Pleural fluid cytology staining and ovarian tissue pathology confirmed the diagnosis of high-grade serous carcinoma of the ovary. Subsequently, she underwent open abdominal cytoreductive surgery for ovarian cancer under general anesthesia, which included total hysterectomy, bilateral salpingo-oophorectomy, and omentectomy. Adjuvant chemotherapy with paclitaxel and carboplatin was administered two weeks after surgery. Amylase levels returned to normal after four weeks. This case suggests that in female patients with unexplained abnormally elevated serum and body fluid amylase levels, clinicians should remain vigilant for the possibility of ovarian cancer. Amylase may serve as an auxiliary diagnostic clue, and its combination with pathological and imaging examinations can facilitate early differentiation. Clinical practice should emphasize the diagnostic value of atypical symptoms and laboratory indicators.

## Linked entities

- **Chemicals:** paclitaxel (PubChem CID 36314), carboplatin (PubChem CID 426756)
- **Diseases:** ovarian carcinoma (MONDO:0005140)

## Full-text entities

- **Diseases:** ovarian cancer (MESH:D010051), pleural effusion (MESH:D010996), chest tightness (MESH:D002637), wheezing (MESH:D012135)
- **Chemicals:** paclitaxel (MESH:D017239), carboplatin (MESH:D016190)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12864134/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12864134/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12864134/full.md

---
Source: https://tomesphere.com/paper/PMC12864134